CASP3 and neoplasm: The model represented the activation of caspase 3 as the final effector of apoptosis, after exposure of tumor cells to 1 or 2 drugs, chosen among 10 different compounds, including 7 kinase inhibitors, 1 cytokine, and 2 chemotherapeutic drugs.